CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)		Preferred Stock	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Redeemable Convertible Preferred Stock		Total
Beginning balance at Feb. 07, 2021		$ 0	$ 0	$ 0	$ 0			$ 0
Beginning balance (in shares) at Feb. 07, 2021			0
Beginning balance at Feb. 07, 2021						$ 0
Beginning balance (in shares) at Feb. 07, 2021	[1]					0
Issuance of Series A Preferred Stock, net of issuance costs ( in shares)	[1]					2,000,000
Issuance of Series A Convertible Preferred Stock, net of issuance costs			$ 2,000	49,313,000				49,315,000
Issuance of Series A Convertible Preferred Stock, net of issuance costs (in shares)			1,739,311			(2,000,000)	[1]
Common stock issuance in conjunction with debt offering, net of issuance costs			$ 1,000	24,638,000				24,639,000
Common stock issuance in conjunction with debt offering, net of issuance costs (in shares)			839,398
Issuance of common stock, net of issuance costs			$ 52,000	104,266,000				104,318,000
Issuance of common stock, net of issuance costs (in shares)			52,261,932
Reverse merger exchange ratio share adjustment			$ 43,000	(43,000)
Reverse merger exchange ratio share adjustment (in shares)			43,136,087
Common stock issued for acquisition of IKONICS Corporation			$ 2,000	40,588,000				40,590,000
Common stock issued for acquisition of IKONICS Corporation (in shares)			1,999,525
Net loss					(95,683,000)			(95,683,000)
Ending balance at Dec. 31, 2021			$ 100,000	218,762,000	(95,683,000)			123,179,000
Ending balance (in shares) at Dec. 31, 2021			99,976,253
Issuance of Series A Convertible Preferred Stock, net of issuance costs		$ 9,273,000						9,273,000
Issuance of Series A Convertible Preferred Stock, net of issuance costs (in shares)		9,566
Warrant issuances in conjunction with debt offering				8,315,000				8,315,000
Warrant issuances in conjunction with equity offering				5,700,000				5,700,000
Stock-based compensation expense				1,568,000				1,568,000
Warrant exercise			$ 6,000	52,000				$ 58,000
Warrant exercise (in shares)			5,714,823					5,714,823
Modifications to embedded conversion feature of convertible promissory notes				1,592,000				$ 1,592,000
Issuance of common stock, net of issuance costs			$ 39,000	58,821,000				58,860,000
Issuance of common stock, net of issuance costs (in shares)			39,801,895
Net loss					(90,791,000)			(90,791,000)
Ending balance at Dec. 31, 2022		$ 9,273,000	$ 145,000	$ 294,810,000	$ (186,474,000)			$ 117,754,000
Ending balance (in shares) at Dec. 31, 2022		9,566	145,492,971

[1] The redeemable convertible preferred stock was presented in the mezzanine section of the consolidated balance sheets while outstanding.